Literature DB >> 15045641

Parvovirus B19 infection and myofasciitis.

Katsuhiro Ichinose, Kiyoshi Migita, Takaharu Sekita, Hisayuki Hamada, Hironori Ezaki, Shigeaki Mukoubara, Katsumi Eguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15045641     DOI： 10.1007/s10067-003-0837-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   3.650


× No keyword cloud information.
  7 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 2.  Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.

Authors:  A Bousvaros; R Sundel; G M Thorne; K McIntosh; M Cohen; D D Erdman; A Perez-Atayde; T H Finkel; A A Colin
Journal:  Pediatr Pulmonol       Date:  1998-11

3.  Lupus-like presentation of human parvovirus B19 infection.

Authors:  R A Kalish; A N Knopf; G W Gary; J J Canoso
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

Review 4.  Human parvovirus B19: historical and clinical review.

Authors:  J Thurn
Journal:  Rev Infect Dis       Date:  1988 Sep-Oct

5.  A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.

Authors:  S Moffatt; N Tanaka; K Tada; M Nose; M Nakamura; O Muraoka; T Hirano; K Sugamura
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Novel transcription map for the B19 (human) pathogenic parvovirus.

Authors:  K Ozawa; J Ayub; Y S Hao; G Kurtzman; T Shimada; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

7.  Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

Authors:  T H Finkel; T J Török; P J Ferguson; E L Durigon; S R Zaki; D Y Leung; R J Harbeck; E W Gelfand; F T Saulsbury; J R Hollister
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321
  7 in total
  3 in total

Review 1.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.

Authors:  Shanmuganathan Chandrakasan; Surjit Singh; R K Ratho; Sharat Kumar; B Mishra
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 3.580

3.  Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions.

Authors:  Itsuro Kazama; Naoko Sasagawa; Toshiyuki Nakajima
Journal:  Case Rep Med       Date:  2012-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.